Vitruvias Therapeutics

Auburn, Alabama finished-dose generic developer and distributor founded in 2013; its Thyroid Tablets USP are among the desiccated thyroid products FDA has never approved.

vitruvias.com

1 story

Regulatory News has published 1 story about Vitruvias Therapeutics on 27 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 27 September 2026.

This page is generated from Regulatory News’ editorial coverage of Vitruvias Therapeutics. It is not an advertisement.

Products in our coverage

Thyroid Tablets, USP30 mg · Lot 504950

Our coverage

1 story, newest first.

A professional reviews a folder of documents outdoors, lanyard and badge visible

For Physicians FDA Recalls Vitruvias Thyroid Tablets Over Superpotency Sep 27, 20266 min read Read the story

All companies